KEY PRODUCTS
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem AG
01 1OCTREOTIDE ACETATE USP
01 1Switzerland
01 1Inactive
01 1Blank
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16760
Submission : 2003-08-13
Status : Inactive
Type : II
20
Bachem Americas Inc, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
One of their notable products is OCTREOTIDE ACETATE USP, with a corresponding US DMF Number 16760.
Remarkably, this DMF maintains an Inactive status since its submission on August 13, 2003, highlighting commitment to regulatory compliance.
